The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis
Yiding Li(National Clinical Research Center for Digestive Diseases), Daiming Fan(National Clinical Research Center for Digestive Diseases), Liaoran Niu(Xijing Hospital), Chenhan Li(Northwest University), Lili Duan(Chinese Academy of Sciences), Junfeng Chen(Anhui Medical University), Liu Hong(National Clinical Research Center for Digestive Diseases), Xiaoqian Wang(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Wanli Yang(National Clinical Research Center for Digestive Diseases), Wei Zhou(Broad Institute), Jinqiang Liu(University of California, Irvine), Yujie Zhang(Harbin Medical University), Guiling Wu(Air Force Medical University)
Cited by 92
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
|Nature Medicine|2017|460
Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches
|Physical Chemistry Chemical Physics|2018|360
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Challenges in the management of acute peptic ulcer bleeding
|The Lancet|2013|234